Statistics on Biotechnology Use  
Results by fields of operation
Business Sector Biotechnology indicators by relevance of biotechnology to company activity.
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.299,559,230,510,
%Companies according to biotechnology used: Genetic code,30,8,39,2,31,4,21,3,
%Companies according to biotechnology used: Functional units,38,4,45,7,43,28,3,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,21,5,26,3,19,8,17,1,
%Companies according to biotechnology used: Bioprocesses,50,8,40,7,54,3,60,2,
%Companies according to biotechnology used: Sub-cellular organisms,8,5,12,7,4,6,5,6,
%Companies according to biotechnology used: Bio-computing,24,34,7,22,1,13,2,
%Companies according to biotechnology used: Nanobiotechnology,12,1,15,6,15,6,6,6,
%Companies according to biotechnology used: Other,16,9,19,2,20,6,12,7,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,5,64,2,36,9,28,8,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,15,5,17,4,16,13,1,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,3,21,34,5,43,8,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,8,20,7,30,9,23,9,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,6,14,1,24,13,5,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,7,14,7,18,5,10,6,
Personnel in R&D in biotechnology (no. of persons),15.750,6.759,3.644,5.347,
Personnel in R&D in biotechnology (no. of persons): Research personnel,8.379,3.802,2.145,2.433,
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel,7.371,2.957,1.500,2.914,
Personnel in R&D in biotechnology (no. of persons). Women,8.711,3.890,2.040,2.782,
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel,4.510,2.078,1.196,1.236,
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel,4.200,1.811,843,1.546,
Personnel in R&D in biotechnology (FTE),11.528,6,5.389,2.417,3,3.722,4,
Personnel in R&D in biotechnology (FTE): Research personnel,6.342,7,3.157,1.493,6,1.692,1,
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel,5.185,9,2.232,923,7,2.030,3,
Personnel in R&D in biotechnology (FTE). Women,6.539,7,3.168,1,1.378,1,1.993,6,
Personnel in R&D in biotechnology (FTE). Women: Research personnel,3.455,7,1.734,1,839,4,882,2,
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel,3.084,1.434,538,7,1.111,4,
Internal expenditure on R&D (thousands of euros),1.038.582,519.104,204.849,314.630,
1) By nature of the expense: Current expenses,940.091,466.051,179.259,294.780,
1.1) Remuneration to research personnel,321.570,164.629,73.301,83.640,
1.2) Remuneration to technicians and auxiliary personnel,194.836,85.747,33.173,75.916,
1.3) Other current expenses,423.685,215.675,72.786,135.225,
2) By nature of the expense: Capital expenses,98.492,53.052,25.589,19.850,
2.1) Land and buildings,10.199,5.434,2.616,2.149,
2.2) Equipment and instruments,72.584,36.725,20.086,15.773,
2.3) Acquisition of specific R+D software,5.721,2.513,2.103,1.104,
2.4) Otros productos de propiedad intelectual específicos para I+D,9.987,8.379,784,823,
1.1) By origin of the funds: Own funds,711.488,314.308,155.688,241.492,
1.2) By origin of the funds: From companies,121.738,80.154,10.983,30.601,
1.3) By origin of the funds: Public Administration funds,107.477,61.083,16.108,30.285,
1.4) By origin of the funds: From Universities,192,68,14,111,
1.5) By origin of the funds: From non profit private institutions,10.756,9.444,0,1.312,
1.6) By origin of the funds: Foreign funds,86.931,54.046,22.055,10.829,
Purchase of R&D services in biotechnology (thousands of euros),145.557,105.405,16.127,24.025,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,95.915,74.486,14.004,7.425,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,49.642,30.919,2.123,16.600,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,40,2,49,4,39,8,30,4,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,2,12,5,15,9,12,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,19,21,5,20,15,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,11,5,10,4,15,1,11,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,15,9,16,1,23,5,12,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,20,6,19,3,11,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,4,16,3,23,1,13,6,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,40,5,46,9,44,1,31,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,55,65,2,55,1,43,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,21,9,24,5,25,17,6,
% Companies with income of an international origin related to biotechnological activities,23,5,33,3,19,8,14,4,
% Turnover representing income of an international origin related to biotechnological activities,1,9,12,1,1,2,1,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,61,6,44,79,9,60,4,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,38,4,56,20,1,39,6,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,87,6,97,73,4,96,5,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,10,9,1,5,25,9,0,9,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,1,1,3,0,7,1,3,
% Income of an international origin related with activities according to the classification: Other,0,4,0,2,0,1,3,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute